Successful Study Start-up for complex Phase I Gene Modified Advanced Therapy Medicinal Product (ATMP) TCR-T (cell immunotherapy) study during the COVID-19 pandemic.
Previous PostGeographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration
